Literature DB >> 2605063

Severe haemolytic anaemia after replacement of the mitral valve by a St Jude medical prosthesis.

H Feld1, J Roth.   

Abstract

Severe haemolytic anaemia developed in a 33 year old patient after the mitral valve was replaced with a St Jude medical prosthesis. This was the patient's third thoracotomy. She had already had a mitral commissurotomy and a mitral valve bioprosthesis. The patient had an E+ antibody to red blood cells as well as a paraprosthetic leak. The haemolysis became less severe once the population of E+ red cells was completely haemolysed. However, the patient continued to require transfusions to remain out of heart failure. Once the valve was replaced, the haemolysis subsided. Fulminant haemolysis after mitral valve replacement is rare. When it does occur, a paraprosthetic leak should be suspected. Other causes of haemolysis, however, must also be considered and these may contribute to the severity of haemolysis.

Entities:  

Mesh:

Year:  1989        PMID: 2605063      PMCID: PMC1216792          DOI: 10.1136/hrt.62.6.475

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  4 in total

1.  Factors influencing hemolysis in valve prosthesis.

Authors:  C Crexells; N Aerichide; Y Bonny; G Lepage; L Campeau
Journal:  Am Heart J       Date:  1972-08       Impact factor: 4.749

Review 2.  Diagnosis and management of complications of prosthetic heart valves.

Authors:  F E Kloster
Journal:  Am J Cardiol       Date:  1975-06       Impact factor: 2.778

3.  Chronic hemolysis following mitral valve replacement. A comparative study of the Björk-Shiley, composite-seat Starr-Edwards, and frame-mounted aortic homograft valves.

Authors:  R Ahmad; S M Manohitharajah; P B Deverall; D A Watson
Journal:  J Thorac Cardiovasc Surg       Date:  1976-02       Impact factor: 5.209

4.  The manual polybrene test: a simple and rapid procedure for detection of red cell antibodies.

Authors:  P Lalezari; A F Jiang
Journal:  Transfusion       Date:  1980 Mar-Apr       Impact factor: 3.157

  4 in total
  1 in total

1.  Percutaneous closure of paravalvular leak in the treatment of anemia of mixed etiology in a patient with diabetic complications and chronic inflammation.

Authors:  Magdalena Pelczarska; Maciej Lewandowski; Jarosław Gorący; Andrzej Wojtarowicz; Robert Sabiniewicz; Grzegorz Wójcik; Zdzisława Kornacewicz-Jach
Journal:  J Geriatr Cardiol       Date:  2016-10       Impact factor: 3.327

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.